
Semax (10mg)
Especificaciones técnicas
| Pureza (HPLC) | ≥99% (HPLC) |
| Número CAS | 80714-61-0 |
| Forma | White lyophilized powder |
| Almacenamiento | -20°C |
| Secuencia | Met-Glu-His-Phe-Pro-Gly-Pro |
| Peso molecular | 813.93 g/mol |
| Forma salina | Acetate |
| Solubilidad | Soluble in water |
Semax (10mg)
Precio de lista en EUR · HU, SK, CZ, PL
- Eurozone (EUR)83,26 EUR
- Hungría (HU)83,26 EUR≈ 33 304 Ft
- Eslovaquia (SK)83,26 EUR
- Chequia (CZ)83,26 EUR≈ 2 082 Kč
- Polonia (PL)83,26 EUR≈ 353,86 zł
Mismo precio de lista en EUR para envío a Hungría, Eslovaquia, República Checa y Polonia. El pago se cobra en EUR.
HUF/CZK/PLN indicativos convertidos desde EUR; Eslovaquia usa EUR. Tasas aproximadas. Cobro en EUR.
ACTH-derived nootropic peptide for cognitive research.
Mechanism: Increases BDNF, modulates dopamine/serotonin, antioxidant protection.
Applications: Ischemic stroke, cognitive enhancement, neuroprotection.
Protocol: Intranasal delivery typical. Reconstitute 1ml BAC water.
Estrictamente para investigación de laboratorio.
No apto para consumo humano, uso veterinario ni diagnóstico.
From the Peptide Explorer
A heptapeptide derived from the ACTH(4-10) fragment, developed at the Institute of Molecular Genetics. Unlike the parent ACTH molecule, Semax lacks corticotropic and steroidogenic activity, instead focusing on nootropic and neuroprotective pathways.
Key Mechanisms
- ›BDNF & NGF upregulation
- ›TrkB receptor activation
- ›Dopaminergic & serotonergic modulation
- ›Acetylcholinesterase inhibition
- ›CREB phosphorylation enhancement
Primary Research Areas
- ›Neuroprotection
- ›Stroke recovery
- ›Cognitive enhancement
- ›Attention disorders
- ›Neurotrophic factor research
Key Research Findings
- Upregulated BDNF by 1.4–3x in rat hippocampus after intranasal administration
- Demonstrated neuroprotective effects in rat MCAO stroke model
- Improved spatial memory in Morris water maze tests
Research Overview
A heptapeptide derived from the ACTH(4-10) fragment, developed at the Institute of Molecular Genetics. Unlike the parent ACTH molecule, Semax lacks corticotropic and steroidogenic activity, instead focusing on nootropic and neuroprotective pathways.
Origin: Synthetic analog of ACTH(4-10) fragment with Pro-Gly-Pro extension
Mechanism of Action
- BDNF & NGF upregulation
- TrkB receptor activation
- Dopaminergic & serotonergic modulation
- Acetylcholinesterase inhibition
- CREB phosphorylation enhancement
Primary Research Areas
- Neuroprotection
- Stroke recovery
- Cognitive enhancement
- Attention disorders
- Neurotrophic factor research
Key Published Findings
- Upregulated BDNF by 1.4–3x in rat hippocampus after intranasal administration
- Demonstrated neuroprotective effects in rat MCAO stroke model
- Improved spatial memory in Morris water maze tests
Research Protocol
Commonly studied routes: Intranasal, Subcutaneous. Reconstitute with bacteriostatic water. Consult published literature for dose ranges; use our Peptide Calculator for volumetric preparation.
Storage
-20°C lyophilized
Important Notice
Semax (10mg) is supplied for laboratory research use only (RUO). Not for human or veterinary use, diagnostics, or therapeutics.
Especificaciones de investigación
Synthesized for strict analytical consistency. Verified via HPLC/MS.Ver estándares de calidad →
Manipulación y almacenamiento
- Store lyophilized at -20°C
- Protect from light and moisture
- Use sterile bacteriostatic water for reconstitution
- Minimize freeze-thaw cycles
- Solubility: Soluble in water